Financing will accelerate the development of human-relevant biological data infrastructure, virtual cell technologies, and next-generation drug discovery , /PRNewswire/ -- Xellar Biosystems today announced the closing of $50 million in Series A and A+ financing to advance its vision of building the world's leading 3D Bio Intelligence platform.